Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Project cooperationUpdated on 11 September 2026

Expertise in HORIZON-HLTH-2027-01-CARE-02

Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences

Kaunas, Lithuania

About

LSMU Kauno Klinikos has extensive experience in clinical management of complex patients receiving multiple treatments, particularly in oncology and chronic disease care. Dr. Kupčinskaitė's expertise in molecular diagnostics and personalized medicine supports the development of individualized treatment strategies that improve efficacy and safety. The institution can contribute clinical evidence, patient cohorts, biomarker-based stratification approaches, and real-world data relevant to treatment optimization. Through multidisciplinary collaboration involving clinicians, pharmacologists, and researchers, LSMU KK can support studies aimed at predicting treatment responses and minimizing adverse drug reactions. The team is particularly interested in innovative approaches combining clinical, molecular, and digital data to improve medication safety and personalized healthcare.

Topic

  • Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities